Medicament delivery device

By setting a locking mechanism, snap connection and elastic arm limit in the drug delivery device, the problems of needle stab wound, sleeve fallout and drug breakage are solved, and the safe, accurate delivery of the drug and device reliability are achieved.

CN221950357UActive Publication Date: 2024-11-05TERUMO MEDICAL PROD (HANGZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202322881301.7
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-10-26
Publication Date
2024-11-05
Estimated Expiration
2033-10-26

AI Technical Summary

Technical Problem

The existing drug delivery device can easily cause the needle tip to be exposed after injection, which can be at risk of needle stab wounds, and the sleeve connection is not firm, which may cause the relay tube and bolus components to fall off. The fixing method of the drug can easily cause the drug to break, and the drug can easily be at the end of the injection. Being taken out of the body.

Method used

A locking mechanism is designed to lock the injection element to prevent the injection element from falling back and exposing the needle tip, fix the safety bracket and relay tube by snapping, set the elastic arm to limit the agent, and use a semi-sphere push end to reduce the drug contact area. .

Benefits of technology

Effectively prevent needle stab injuries, ensure reliable product connection, reduce the risk of drug breakage and taking it out of the body, and achieve accurate and safe delivery of drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221950357U_ABST
    Figure CN221950357U_ABST
Patent Text Reader

Abstract

The utility model provides a medicament delivery device, which comprises a syringe with a near end and a far end; the storage container is fixed in the near end of the syringe, and the storage container is provided with a storage unit used for containing a solid implantation medicament; the puncture needle is fixed at the near end of the syringe and is communicated with the storage unit of the storage container; the injection element is mounted in the far end of the syringe and used for pushing the solid implantation medicament into the puncture needle, and the injection element can move in the storage container and extend into the puncture needle; wherein a locking mechanism for locking the injection element is arranged at the far end of the syringe. By arranging the locking mechanism used for locking the injection element, interlocking of the injection element and the syringe can be achieved, and therefore the risk of needle pricking injury is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical equipment, in particular to a medicine delivery device. Background Art

[0002] Needlestick injuries pose a serious threat to human health and may lead to infection with infectious diseases such as hepatitis B, hepatitis C, HIV, etc., and may easily cause various complications or even death. Therefore, needlestick injuries will cause psychological and physiological trauma, and may even cause severe damage to patients and a serious economic burden. Therefore, cross-infection caused by needlestick injuries is unacceptable. Needles need to be protected after puncture to prevent needlestick injuries, such as covering the needle after use.

[0003] The existing drug delivery devices mainly have the following problems: 1. After the injection is completed, the tip of the syringe push rod will be forced to move back, causing the steel needle to be exposed, which may easily cause the risk of accidental needle sticking and the hidden danger of failure of the safety device; 2. The connection of the sleeve inside the product is unreliable, which may cause the connecting buckle to crack, causing the relay tube and the push injection component to easily fall off from the product body, thereby rendering the product unusable; 3. The position of the medicine is fixed by the elastic arm of the storage container clamping the medicine for a long time. Long-term force on the medicine is prone to the risk of medicine breakage; 4. The contact area between the head end of the push rod and the medicine is too large, and there is a risk of the medicine being brought out of the body during injection. Utility Model Content

[0004] In order to solve the technical problems existing in the prior art, an embodiment of the utility model provides a drug delivery device, which can achieve interlocking of the injection element and the syringe barrel by providing a locking mechanism for locking the injection element, thereby avoiding the risk of needle stick injury caused by the needle tip being exposed again after the puncture is completed.

[0005] According to an embodiment of the utility model, a drug delivery device is provided. The drug delivery device comprises: a syringe having a proximal end and a distal end; a storage container fixed to the proximal end of the syringe, the storage container having a storage unit for containing a solid implant drug; a puncture needle fixed to the proximal end of the syringe and connected to the storage unit of the storage container; and an injection element installed in the distal end of the syringe, used to push the solid implant drug into the puncture needle, the injection element being able to move in the storage container and extend into the puncture needle; wherein the distal end of the syringe is provided with a locking mechanism for locking the injection element.

[0006] By providing a locking mechanism for locking the injection element, the injection element and the syringe are interlocked, which can prevent the injection element from being forced to retreat and cause the puncture needle to be exposed, thereby avoiding the risk of the puncture needle tip being exposed again and causing a needle stick injury.

[0007] Optionally, the injection component is provided with a pressing portion, and the locking mechanism is used to lock the pressing portion of the injection component.

[0008] Optionally, the drug delivery device also includes: a relay tube installed in the distal end of the syringe and located between the injection element and the syringe; and a safety bracket installed in the proximal end of the syringe and located between the puncture needle and the syringe; wherein the safety bracket is fixed to the relay tube by a snap-fit ​​method.

[0009] The safety bracket is fixed to the relay tube by means of a snap-fit, providing a reliable connection between the safety bracket and the relay tube, thereby preventing the safety bracket and the relay tube from falling off during use or transportation, thereby preventing the product from being unusable.

[0010] Optionally, the male buckle includes a main body and two snap-on parts extending from both sides of the main body, and the female buckle includes a groove part and two limiting parts protruding from the inner wall of the groove part, the groove part is used to accommodate the main body, and the limiting part is used to lock the snap-on parts.

[0011] Optionally, the main body has a central hole; or the main body includes two clamping arms arranged at intervals, and the two buckle parts are respectively arranged on the outer sides of the two clamping arms.

[0012] Optionally, a chamfer is provided at the connection between the male buckle and the safety bracket, which helps to reduce the risk of the male buckle breaking.

[0013] Optionally, an elastic arm is provided in the storage container, and a protrusion for interference limiting the solid implant medicine is provided at the end of the elastic arm.

[0014] Providing the protrusion of the elastic arm to perform interference limiting on the solid implant medicine helps to reduce the risk of the medicine being broken or damaged due to being clamped by the storage container for a long time.

[0015] Optionally, the injection element has a semi-spherical or semi-ellipsoidal pushing end.

[0016] Providing a semi-spherical or semi-ellipsoidal pushing end can help reduce the contact area between the injection element and the medicine, thereby reducing the risk of the medicine being adhered to the injection element and carried out of the body after the push injection is completed.

[0017] Optionally, a pushing portion is provided at the center of the pushing end.

[0018] The drug delivery device of the utility model realizes accurate and convenient delivery of solid implant drugs, avoids needle stick injuries in the whole process, and is safe and easy to operate. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Other features and advantages of the present invention will be better understood through the optional embodiments described in detail below in conjunction with the accompanying drawings, in which the same reference numerals represent the same or similar components, wherein:

[0020] Figure 1 A schematic diagram of a drug delivery device according to an embodiment of the present utility model is shown;

[0021] Figure 2 Shows Figure 1 A cross-sectional view of the drug delivery device of the embodiment shown in , wherein the protective cover is removed;

[0022] Figures 3 to 5 Shows Figure 1 Schematic diagrams of different usage states of the drug delivery device of the embodiment shown in FIG.

[0023] Figure 6 A partially enlarged schematic diagram of a locking mechanism of a drug delivery device according to an embodiment of the utility model is shown;

[0024] Figure 7 A partial enlarged schematic diagram of a female buckle of a relay tube of a drug delivery device according to an embodiment of the utility model is shown;

[0025] Figure 8 A partially enlarged schematic diagram of a male buckle of a safety bracket of a drug delivery device according to an embodiment of the utility model is shown;

[0026] Fig. 9 A partial enlarged schematic diagram of a female buckle of a relay tube of a drug delivery device according to another embodiment of the utility model is shown;

[0027] Fig.10 A partial enlarged schematic diagram of a male buckle of a safety bracket of a drug delivery device according to another embodiment of the utility model is shown;

[0028] Fig.11 A schematic diagram showing a connection method between a safety bracket and a relay tube of a drug delivery device according to another embodiment of the utility model is shown;

[0029] Fig.12 A partially enlarged schematic diagram of an elastic arm of a storage container of a drug delivery device according to an embodiment of the utility model is shown;

[0030] Fig.13A and Fig. 13B A schematic diagram showing a push end of an injection element of a drug delivery device according to an embodiment of the present invention; and

[0031] Fig.14A and Fig. 14BA schematic diagram showing a pushing portion of an injection element of a drug delivery device according to an embodiment of the present invention is shown. DETAILED DESCRIPTION

[0032] The implementation and use of the embodiments are discussed in detail below. However, it should be understood that the specific embodiments discussed are merely exemplary of specific ways to implement and use the present invention, and are not intended to limit the scope of the present invention. When describing the structural positions of the various components, such as up, down, top, bottom, etc., the expressions of directions are not absolute, but relative. When the various components are arranged as shown in the figure, these directional expressions are appropriate, but when the positions of the various components in the figure change, these directional expressions also change accordingly.

[0033] An embodiment of the utility model provides a drug delivery device. The drug delivery device includes: a syringe having a proximal end and a distal end; a storage container fixed to the proximal end of the syringe, the storage container having a storage unit for accommodating a solid implant drug; a puncture needle fixed to the proximal end of the syringe and connected to the storage unit of the storage container; and an injection element installed in the distal end of the syringe, used to push the solid implant drug into the puncture needle, the injection element can move in the storage container and extend into the puncture needle; wherein the distal end of the syringe is provided with a locking mechanism for locking the injection element. By providing a locking mechanism for locking the injection element, the injection element and the syringe are interlocked, which can prevent the injection element from being forced to retreat and cause the puncture needle to be exposed, thereby avoiding the risk of the puncture needle tip being exposed again and causing a needle stick injury.

[0034] The structure and function of the drug delivery device 100 according to the embodiment of the utility model will be described in detail below with reference to the accompanying drawings.

[0035] like Figure 1 and Figure 2 As shown in , the drug delivery device 100 includes a syringe, such as an outer barrel 10, a storage container, such as a cartridge 20, a puncture needle 30, and an injection element, such as a push rod 40. The outer barrel 10 has a proximal end and a distal end. The cartridge 20 is fixed to the proximal end of the outer barrel 10, such as by interference fit, and the cartridge 20 has a storage unit, such as a chamber, for accommodating a solid implant drug 70. The puncture needle 30 is used to establish a subcutaneous injection channel for the patient. The puncture needle 30 is fixed to the proximal end of the outer barrel 10, such as by dispensing or insert molding, and is connected to the chamber of the cartridge 20. The push rod 40 is installed in the distal end of the outer barrel 10, and is used to push the solid implant drug 70 into the puncture needle 30. The push rod 40 can move back and forth in the cartridge 20 and extend into the puncture needle 30. In combination Figures 4 to 6 As shown in FIG, the distal end of the outer tube 10 is provided with a locking mechanism for locking the push rod 40, such as a locking buckle 11. The proximal end herein refers to a direction close to the puncture needle 30, and the distal end refers to a direction away from the puncture needle 30.

[0036] By providing a locking buckle 11 for locking the push rod 40, the push rod 40 and the outer tube 10 are interlocked, which can prevent the push rod 40 from being forced to retreat and cause the puncture needle 30 to be exposed, thereby avoiding the risk of the needle tip of the puncture needle 30 being exposed again and causing a needle stick injury.

[0037] In some embodiments, the push rod 40 is provided with a pressure portion, such as a push rod seat 41, and the locking buckle 11 is used to lock the push rod seat 41 of the push rod 40. In other embodiments, the push rod 40 and the push rod seat 41 can be two separate components, and the push rod 40 is fixed to the push rod seat 41 by, for example, dispensing or insert molding.

[0038] Combination Figures 3 to 5 As shown in , in some embodiments, the drug delivery device 100 further includes a relay tube 50 and a safety bracket 60. The relay tube 50 is installed in the distal end of the outer tube 10 and is located between the push rod 40 and the outer tube 10. The safety bracket 60 is installed in the proximal end of the outer tube 10 and is located between the puncture needle 30 and the outer tube 10. Among them, the safety bracket 60 is fixed to the relay tube 50 by snapping. The cartridge 20 is located in the relay tube 50 and the safety bracket 60, and the relay tube 50 moves relative to the safety bracket 60 and the outer tube 10 during use. In some embodiments, the relay tube 50 can move in the outer tube 10, thereby driving the safety bracket 60 to move, so that the safety bracket 60 wraps the outer surface of the puncture needle 30 after the injection is completed, thereby preventing needle stick injuries.

[0039] Combination Figure 7 and Figure 8 As shown in , in some embodiments, a male buckle 61 is provided on the safety bracket 60, and a female buckle 51 matching with the male buckle 61 is provided on the relay tube 50. The safety bracket 60 is buckled to the relay tube 50 by buckling the male buckle 61 to the female buckle 51.

[0040] In some embodiments, the male buckle 61 includes a body portion 611 and two buckle portions 612 extending outward from both sides of the body portion 611, and the female buckle 51 includes a groove portion 511 and two stopper portions 512 protruding from the inner wall of the groove portion 511. The distance between the two stopper portions 512 is smaller than the distance between the two buckle portions 612, the groove portion 511 is used to accommodate the body portion 611, and the stopper portion 512 is used to lock the buckle portion 612.

[0041] In some embodiments, the buckle portion 612 has a first inclined surface 6121 , and the limiting portion 512 has a second inclined surface 5121 matching the first inclined surface 6121 , which facilitates the insertion of the male buckle 61 into the female buckle 51 .

[0042] During the process of inserting the safety bracket 60 into the relay tube 50, the inner wall of the groove portion 511 squeezes the two snap portions 612, causing the main body portion 611 to deform and become narrower. After the safety bracket 60 is inserted into the relay tube 50, the main body portion 611 restores its deformation, and the two limiting portions 512 respectively contact the two snap portions 612 and lock the two snap portions 612.

[0043] In some embodiments, the main body 611 has a central hole 613 , and the setting of the central hole 613 is conducive to providing a certain degree of elasticity.

[0044] Combination Fig. 9 and Fig.10 As shown in , in some embodiments, the main body 611 of the male buckle 61 includes two clamping arms 6111 arranged at a certain distance, and the two clamping portions 612 are respectively arranged on the outer sides of the two clamping arms 6111.

[0045] In some embodiments, the groove portion 511 of the female buckle 51 is trapezoidal. The buckle portion 612 has a first inclined surface 6121 , and the stopper portion 512 has a second inclined surface 5121 matched with the first inclined surface 6121 , which is conducive to the male buckle 61 being inserted into the female buckle 51 .

[0046] Combination Fig.11 As shown, during the process of inserting the safety bracket 60 into the relay tube 50, the two clamping arms 6111 are pressed to deform them and enter the groove portion 511. After the safety bracket 60 is inserted into the relay tube 50, the two clamping arms 6111 restore their deformation, and the two buckle portions 612 are respectively buckled into the two limit portions 512, thereby realizing the connection between the relay tube 50 and the safety bracket 60.

[0047] The safety bracket 60 is fixed to the relay tube 50 by snapping, which provides a reliable connection between the safety bracket 60 and the relay tube 50, thereby preventing the safety bracket 60 and the relay tube 50 from falling off during use or transportation, thereby preventing the product from being unusable.

[0048] In some embodiments, a chamfer is provided at the connection between the clamping arm 6111 of the main body 611 of the male buckle 61 and the safety bracket 60, which helps to reduce the risk of the clamping arm 6111 of the main body 611 of the male buckle 61 breaking.

[0049] Combination Fig.12 As shown in , in some embodiments, an elastic arm 22 is provided in the cartridge 20, and a protrusion 221 for interference limiting the solid implanted medicine 70 is provided at the end of the elastic arm 22. By providing the protrusion 221 of the elastic arm 22 to interfere with the solid implanted medicine 70, it is helpful to reduce the risk of the medicine being clamped by the cartridge 20 for a long time, which may cause the medicine to break or be damaged.

[0050] Combination Fig.13A and Fig. 13B As shown in , in some embodiments, the push rod 40 has a push end 42, and the push end 42 can be semi-spherical, semi-elliptical or other shapes. By providing a semi-spherical or semi-elliptical push end 42, it is beneficial to reduce the contact area between the push rod 40 and the solid implant medicine 70, thereby reducing the risk of the medicine being adhered to the push rod and taken out of the body after the injection is completed.

[0051] In some embodiments, the push rod 40 may be made of a material that is not prone to adhesion, such as PTFE.

[0052] Combination Fig.14A and Fig. 14B As shown in , in some embodiments, a pushing portion 421 is provided at the center of the pushing end 42, and the pushing portion 421 can be cylindrical, semi-spherical, semi-elliptical or other shapes. By providing the pushing portion 421 at the center, it is beneficial to further reduce the contact area between the push rod 40 and the solid implant medicine 70.

[0053] In some embodiments, Figure 1 As shown in , the drug delivery device 100 further includes a limit clamp 80 for limiting the movement of the push rod 40. The limit clamp 80 can be sleeved on the outside of the relay tube 50 to prevent the push rod seat 41 and the push rod 40 from moving before use.

[0054] In some embodiments, Figure 1 As shown in , the drug delivery device 100 also includes a protective cover 90 for preventing puncture injuries. The protective cover 90 can be sleeved on the outside of the puncture needle 30 to prevent the steel needle from being damaged and to prevent needle puncture injuries.

[0055] Combination Figures 3 to 5 As shown in the figure, when in use, first remove the limit clip 80 and the protective cover 90, then puncture the patient's skin, insert the puncture needle 30 into the subcutaneous tissue, and then push the push rod seat 41. Driven by the push rod seat 41, the push rod 40 pushes the solid implant medicine 70 to the front end of the puncture needle 30, and the front end of the solid implant medicine 70 is flush with the root of the bevel of the puncture needle 30.

[0056] Then, the push rod seat 41 is pushed toward the needle tip of the puncture needle 30, and the push rod seat 41 contacts the relay tube 50, driving the relay tube 50 to enter the outer tube 10. Since the push rod 40 is connected to the push rod seat 41, the push rod seat 41, the relay tube 50, the safety bracket 60 and the push rod 40 remain stationary at this time, and the outer tube 10 is pulled back outward. The front end of the push rod 40 is always against the solid implant medicine 70, so the solid implant medicine 70 does not retreat and remains at the implantation site. During the retraction process of the outer tube 10, since the outer tube 10, the cartridge 20 and the puncture needle 30 are connected together, the outer tube 10, the cartridge 20 and the puncture needle 30 retreat together, and the position of the front end of the push rod 40 remains stationary.

[0057] As the outer cylinder 10, the cartridge 20 and the puncture needle 30 gradually retract, the length of the push rod 40 that exposes the needle tip of the puncture needle 30 becomes longer and longer. Although needle stick injuries can be prevented at this time, the push rod 40 and the puncture needle 30 can move back and forth relative to each other, and the push rod 40 may retract into the puncture needle 30, thereby causing needle stick injuries. By adding the locking buckle 11, the outer cylinder 10 continues to retract, and the puncture needle 30 is completely wrapped by the safety bracket 60. The outer cylinder 10 continues to retract until the locking buckle 11 is activated, and the push rod seat 41 and the outer cylinder 10 are interlocked, at which time the needle tip of the puncture needle 30 is completely prevented from being exposed again, causing the risk of needle stick injuries.

[0058] Considering that the push rod 40 is easy to retreat, the puncture needle 30 is exposed and punctures are easy to occur, in order to ensure the reliability of the activation of the safety device, the locking buckle 11 is added to ensure the cooperation and improve the destructive strength of the safety device.

[0059] By providing the protrusion 221 of the elastic arm 22 to perform interference limiting on the solid implant medicine 70, the medicine will not be clamped for a long time, and the risk of the medicine being broken due to long-term clamping can be reduced.

[0060] Considering the planar contact between the push rod 40 and the medicine, long-term contact may cause the medicine to adhere to the push rod. After the push injection is completed, there is a risk that the medicine will be carried out of the body due to the push rod adhesion during the needle withdrawal process, resulting in injection failure. By providing a semi-spherical or semi-elliptical push end, the contact area between the push rod and the medicine is reduced, and the risk of the medicine being carried out of the body by the push rod adhesion after the push injection is completed is reduced.

[0061] The technical content and technical features of the utility model have been disclosed above. However, it can be understood that under the creative idea of ​​the utility model, technicians in this field can make various changes and improvements to the above-disclosed concepts, but they all belong to the protection scope of the utility model. The description of the above implementation mode is illustrative rather than restrictive, and the protection scope of the utility model is determined by the claims.

Claims

1. A drug delivery device, characterized in that: include: a syringe having a proximal end and a distal end; a storage container fixed to the proximal end of the syringe, the storage container having a storage unit for containing a solid implantable medicament; a puncture needle fixed to the proximal end of the syringe and connected to the storage unit of the storage container; as well as An injection element, mounted in the distal end of the syringe, for pushing the solid implant medicament into the puncture needle, the injection element being movable in the storage container and extending into the puncture needle; Wherein, the distal end of the injection barrel is provided with a locking mechanism for locking the injection element.

2. The drug delivery device according to claim 1, characterized in that: The injection component is provided with a pressing portion, and the locking mechanism is used to lock the pressing portion of the injection component.

3. The drug delivery device according to claim 1, characterized in that: The drug delivery device further comprises: a relay tube mounted in the distal end of the syringe barrel and located between the injection element and the syringe barrel; and A safety bracket installed in the proximal end of the syringe and located between the puncture needle and the syringe; Wherein, the safety bracket is fixed to the relay tube by snap-fitting.

4. The drug delivery device according to claim 3, characterized in that: The safety bracket is provided with a male buckle, and the relay pipe is provided with a female buckle matched with the male buckle.

5. The drug delivery device according to claim 4, characterized in that: The male buckle includes a main body and two buckle parts extending from both sides of the main body, and the female buckle includes a groove part and two limiting parts protruding from the inner wall of the groove part, the groove part is used to accommodate the main body, and the limiting part is used to lock the buckle part.

6. The drug delivery device according to claim 5, characterized in that: The body portion has a central hole; or The main body comprises two clamping arms which are arranged at intervals, and the two buckle parts are respectively arranged on the outer sides of the two clamping arms.

7. The drug delivery device according to claim 4, characterized in that: A chamfer is provided at the connection between the male buckle and the safety bracket.

8. The drug delivery device according to any one of claims 1 to 7, characterized in that: An elastic arm is arranged in the storage container, and a protrusion for interference limiting the solid implant medicine is arranged at the end of the elastic arm.

9. The drug delivery device according to any one of claims 1 to 7, characterized in that: The injection element has a semi-spherical or semi-ellipsoidal pushing end.

10. The drug delivery device according to claim 9, characterized in that: A pushing portion is provided at the center of the pushing end.